Israel

Ellomay Capital Ltd. Announces a Proposed Private Placement of Ordinary Shares to Israeli Institutional and Classified Investors for Approximately NIS 31.7 Million

Thursday, July 9, 2020 - 9:30pm

The price per share in the Private Placement was set at NIS 70.5 (approximately $20.4) and the gross proceeds to the Company are expected to be approximately NIS 31.7 million.

Key Points: 
  • The price per share in the Private Placement was set at NIS 70.5 (approximately $20.4) and the gross proceeds to the Company are expected to be approximately NIS 31.7 million.
  • The closing price per share on July 6, 2020 and July 7, 2020 on the Tel Aviv Stock Exchange was NIS 69.52 and NIS 72.04, respectively.
  • The closing of the Private Placement is subject to the receipt of regulatory approvals, which are expected to be obtained during July 2020.
  • The Private Placement described in this report, if made, will be made in Israel only and not to U.S. persons.

Teva to Host Conference Call to Discuss Second Quarter 2020 Financial Results at 8 a.m. ET on August 5, 2020

Thursday, July 9, 2020 - 9:00pm

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter financial results on Wednesday August 5, 2020 at 7:00 a.m.

Key Points: 
  • Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter financial results on Wednesday August 5, 2020 at 7:00 a.m.
  • Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m.
  • Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software.
  • Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve peoples lives for more than a century.

Unconventional Weapon in the War on Cancer Revealed: Immunicom and Sheba Medical Center Initiate Clinical Trial to Evaluate Breakthrough Oncology Treatment, Immunopheresis Therapy

Thursday, July 9, 2020 - 7:00pm

The LW-02 device has received Breakthrough Device designation for stage IV metastatic cancer from the U.S. Food and Drug Administration (FDA).

Key Points: 
  • The LW-02 device has received Breakthrough Device designation for stage IV metastatic cancer from the U.S. Food and Drug Administration (FDA).
  • Hagit Harati, head nurse and co-founder of the newly established Immunopheresis Unit at Sheba, will be responsible of trial execution.
  • In addition to this new clinical evaluation of Immunopheresis at Sheba Medical Center to treat several cancers, Immunopheresis is currently being evaluated in Poland to treat triple-negative breast cancer (TNBC) in an ongoing clinical trial.
  • Sheba Medical Center, Tel HaShomer is the largest and most comprehensive medical center in the Middle East.

Firedome Welcomes Cybersecurity Industry Pioneer Alex Ionescu to Advisory Board

Thursday, July 9, 2020 - 6:00pm

NEW YORK, July 9, 2020 /PRNewswire/ -- Firedome , provider of an advanced privacy, cybersecurity and insights platform tailor-made for IoT device brands, today announced that Alex Ionescu, VP of Endpoint Engineering at CrowdStrike, has joined their Advisory Board.

Key Points: 
  • NEW YORK, July 9, 2020 /PRNewswire/ -- Firedome , provider of an advanced privacy, cybersecurity and insights platform tailor-made for IoT device brands, today announced that Alex Ionescu, VP of Endpoint Engineering at CrowdStrike, has joined their Advisory Board.
  • "We are very excited to have Alex join our Advisory Board at Firedome.
  • Alex Ionescu is VP of Endpoint Engineering at CrowdStrike, Inc., where he started as the Founding Chief Architect in 2011.
  • Alex is a world-class security architect and consultant expert in low-level system software, kernel development, security training, and reverse engineering.

Binah.ai Awarded Best Digital Health Innovation by Juniper Research

Thursday, July 9, 2020 - 4:00pm

TEL AVIV, Israel, July 9, 2020 /PRNewswire-PRWeb/ -- Binah.ai , the leading provider of general health and wellness video-based monitoring tools powered by artificial intelligence (AI), today announced that it is the recipient of two 2020 Future Digital Awards , Best Digital Health Innovation and Outstanding Achievement in Technology.

Key Points: 
  • TEL AVIV, Israel, July 9, 2020 /PRNewswire-PRWeb/ -- Binah.ai , the leading provider of general health and wellness video-based monitoring tools powered by artificial intelligence (AI), today announced that it is the recipient of two 2020 Future Digital Awards , Best Digital Health Innovation and Outstanding Achievement in Technology.
  • The company received the award from Juniper Research , an analyst house that specializes in digital technology market research and trends.
  • "We are honored to be recognized by Juniper Research as a leading innovator in the digital health space," said David Maman, CEO and co-founder of Binah.ai.
  • With its impactful solution, competitive edge and strong overall performance, Binah.ai has earned both the 2020 Juniper Research Company's Future Digital Award for Best Digital Health Innovation and Outstanding Achievement in Technology," said Elson Sutanto, Principal Analyst at Juniper Research.

The Mark Hotel Ranked "#1 City Hotel in the US" and "#1 Hotel in New York City" in Travel + Leisure World's Best Awards 2020

Thursday, July 9, 2020 - 3:45pm

NEW YORK, July 9, 2020 /PRNewswire/ -- The iconic Mark Hotel,which reopened its doorson June 15th and is located in one of Manhattan's most elegant and discreet neighborhoods in the heart of the Upper East Side, has been voted "#1 City Hotel in the Continental United States"and "#1 Hotel in New York City"in the Travel + Leisure World's Best Awards for 2020.

Key Points: 
  • NEW YORK, July 9, 2020 /PRNewswire/ -- The iconic Mark Hotel,which reopened its doorson June 15th and is located in one of Manhattan's most elegant and discreet neighborhoods in the heart of the Upper East Side, has been voted "#1 City Hotel in the Continental United States"and "#1 Hotel in New York City"in the Travel + Leisure World's Best Awards for 2020.
  • "We are doubly honored to receive two major awards, namelyBest Hotel in New York andBest City Hotel in the US by Travel + Leisure World's Best Awards of 2020.
  • Our management team, creative team, staff and collaborators, including Michelin star chef Jean-Georges Vongerichten, beauty entrepreneur Frdric Fekkai and master perfumer Frdric Malle, are the very reason for our success."
  • The Mark Hotelcombines avant-garde design with the latest technology and old-world comfort.

The Mark Hotel Ranked "#1 City Hotel in the US" and "#1 Hotel in New York City" in Travel + Leisure World's Best Awards 2020

Thursday, July 9, 2020 - 3:30pm

NEW YORK, July 9, 2020 /PRNewswire/ -- The iconic Mark Hotel,which reopened its doorson June 15th and is located in one of Manhattan's most elegant and discreet neighborhoods in the heart of the Upper East Side, has been voted "#1 City Hotel in the Continental United States"and "#1 Hotel in New York City"in the Travel + Leisure World's Best Awards for 2020.

Key Points: 
  • NEW YORK, July 9, 2020 /PRNewswire/ -- The iconic Mark Hotel,which reopened its doorson June 15th and is located in one of Manhattan's most elegant and discreet neighborhoods in the heart of the Upper East Side, has been voted "#1 City Hotel in the Continental United States"and "#1 Hotel in New York City"in the Travel + Leisure World's Best Awards for 2020.
  • "We are doubly honored to receive two major awards, namelyBest Hotel in New York andBest City Hotel in the US by Travel + Leisure World's Best Awards of 2020.
  • Our management team, creative team, staff and collaborators, including Michelin star chef Jean-Georges Vongerichten, beauty entrepreneur Frdric Fekkai and master perfumer Frdric Malle, are the very reason for our success."
  • The Mark Hotelcombines avant-garde design with the latest technology and old-world comfort.

hiSky Reveals its Smartellite™ Dynamic Ku-band Terminal, Based on Phased Array Antenna Technology

Thursday, July 9, 2020 - 3:09pm

Based on hiSky's innovative Smartellite Dynamic Ka-band terminal, the Ku-band terminal offers the same advantages in terms of on-the-move capabilities, weight, size and price.

Key Points: 
  • Based on hiSky's innovative Smartellite Dynamic Ka-band terminal, the Ku-band terminal offers the same advantages in terms of on-the-move capabilities, weight, size and price.
  • It also uses the same building blocks, such as a built-in modem and phased array antenna technology, and connects to hiSky's comprehensive Network Management System (NMS), hiSky360 managing both Ka and Ku-band terminals on the same network.
  • "The development of the Ku terminal is another milestone in our company's growth process and product portfolio," says Shahar Kravitz, Co-Founder and CEO of hiSky.
  • All the technology integrated into hiSky products is developed in-house, enabling the company to adapt to specific customer requirements and respond quickly to market demands.

Therapix Biosciences Announces OTC Pink Ticker Symbol 'TRPXY' and Removal of Injunction by Israeli Court

Thursday, July 9, 2020 - 2:08pm

As of July 8, 2020, the Company's ADSs became eligible to trade on the OTC Pink Marketplace under the symbols "TRPXY."

Key Points: 
  • As of July 8, 2020, the Company's ADSs became eligible to trade on the OTC Pink Marketplace under the symbols "TRPXY."
  • The Company previously announced that the listing of its ADSs was suspended by the Nasdaq Stock Market as of July 2, 2020.
  • On July 8, 2020, during a court hearing following the previously granted temporary injunction, the Israeli court ruled as follows:
    1.
  • About Therapix Biosciences (OTC Pink: TRPXY):
    Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists.

ADAMA Publishes 2018-19 Sustainability Report

Thursday, July 9, 2020 - 2:08pm

Michal Arlosoroff, ADAMA's EVP, General Legal Counsel and Company Secretary & Chief Sustainability Officer, added: "Our commitment to sustainability remains steadfast and is growing even stronger.

Key Points: 
  • Michal Arlosoroff, ADAMA's EVP, General Legal Counsel and Company Secretary & Chief Sustainability Officer, added: "Our commitment to sustainability remains steadfast and is growing even stronger.
  • We have outlined specific goals in the report, showing our commitment to incorporate sustainability as an even stronger part of our strategy and business commitments".
  • The report is available on our newly dedicated website: Sustainability Site .
  • ADAMA Ltd. is a global leader in crop protection, providing solutions to farmers across the world to combat weeds, insects and disease.